ReP USP - Resultado da busca

Artigo de periodico
Lipid transfers to HDL are diminished in long‑term bedridden patients: association with low HDL‑cholesterol and increased inflammatory markers (2017)
Oliveira, Wilson Pascoalino Camargo de; Tavoni, Thauany Martins; Freitas, Fatima Rodrigues; Silva, Bruna Miranda de Oliveira; Maranhão, Raul Cavalcante
Fonte: Lipids. Unidade: FCF
Assuntos: COLESTEROL, LIPOPROTEÍNAS HDL, LIPÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Wilson Pascoalino Camargo de et al. Lipid transfers to HDL are diminished in long‑term bedridden patients: association with low HDL‑cholesterol and increased inflammatory markers. Lipids, v. 52, p. 703-709, 2017Tradução . . Disponível em: https://doi.org/10.1007/s11745-017-4274-x. Acesso em: 16 nov. 2024.
APA
Oliveira, W. P. C. de, Tavoni, T. M., Freitas, F. R., Silva, B. M. de O., & Maranhão, R. C. (2017). Lipid transfers to HDL are diminished in long‑term bedridden patients: association with low HDL‑cholesterol and increased inflammatory markers. Lipids, 52, 703-709. doi:10.1007/s11745-017-4274-x
NLM
Oliveira WPC de, Tavoni TM, Freitas FR, Silva BM de O, Maranhão RC. Lipid transfers to HDL are diminished in long‑term bedridden patients: association with low HDL‑cholesterol and increased inflammatory markers [Internet]. Lipids. 2017 ; 52 703-709.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s11745-017-4274-x
Vancouver
Oliveira WPC de, Tavoni TM, Freitas FR, Silva BM de O, Maranhão RC. Lipid transfers to HDL are diminished in long‑term bedridden patients: association with low HDL‑cholesterol and increased inflammatory markers [Internet]. Lipids. 2017 ; 52 703-709.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s11745-017-4274-x
Trabalho de evento-resumo periodico
Expression of mir-33a/b in hepatoma cells treated with atorvastatin (2012)
Zambrano, T; Cerda, Alvaro; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Salazar, Luís Antônio
Fonte: Drug Metabolism and Drug Interactions. Nome do evento: Santorine Conference Biologie Prospective. Unidade: FCF
Assuntos: EXPRESSÃO GÊNICA, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZAMBRANO, T et al. Expression of mir-33a/b in hepatoma cells treated with atorvastatin. Drug Metabolism and Drug Interactions. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 16 nov. 2024. , 2012
APA
Zambrano, T., Cerda, A., Hirata, M. H., Hirata, R. D. C., & Salazar, L. A. (2012). Expression of mir-33a/b in hepatoma cells treated with atorvastatin. Drug Metabolism and Drug Interactions. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Zambrano T, Cerda A, Hirata MH, Hirata RDC, Salazar LA. Expression of mir-33a/b in hepatoma cells treated with atorvastatin. Drug Metabolism and Drug Interactions. 2012 ; 27( 3): A34 res. B28.[citado 2024 nov. 16 ]
Vancouver
Zambrano T, Cerda A, Hirata MH, Hirata RDC, Salazar LA. Expression of mir-33a/b in hepatoma cells treated with atorvastatin. Drug Metabolism and Drug Interactions. 2012 ; 27( 3): A34 res. B28.[citado 2024 nov. 16 ]
Trabalho de evento-resumo periodico
Anti-inflammatory properties of HDL after short-term exercise training in patients with metabolic syndrome (2012)
Casella Filho, Antonio; Trombetta, Ivani Credidio; Casella, L. B; Dourado, Paulo Magno Martins; Segre, A; Favarato, Desiderio; Borges, L. Roever; Negrão, C. E; Maranhão, Raul Cavalcante ; Chagas, Antonio Carlos Palandri
Fonte: European Heart Journal. Nome do evento: ESC Congress. Unidades: EEFE, FCF
Assuntos: DOENÇAS CARDIOVASCULARES, ATIVIDADE FÍSICA, ANTI-INFLAMATÓRIOS, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASELLA FILHO, Antonio et al. Anti-inflammatory properties of HDL after short-term exercise training in patients with metabolic syndrome. European Heart Journal. London: Escola de Educação Física e Esporte, Universidade de São Paulo. Disponível em: http://eurheartj.oxfordjournals.org/content/33/suppl_1/19.full.pdf+html. Acesso em: 16 nov. 2024. , 2012
APA
Casella Filho, A., Trombetta, I. C., Casella, L. B., Dourado, P. M. M., Segre, A., Favarato, D., et al. (2012). Anti-inflammatory properties of HDL after short-term exercise training in patients with metabolic syndrome. European Heart Journal. London: Escola de Educação Física e Esporte, Universidade de São Paulo. Recuperado de http://eurheartj.oxfordjournals.org/content/33/suppl_1/19.full.pdf+html
NLM
Casella Filho A, Trombetta IC, Casella LB, Dourado PMM, Segre A, Favarato D, Borges LR, Negrão CE, Maranhão RC, Chagas ACP. Anti-inflammatory properties of HDL after short-term exercise training in patients with metabolic syndrome [Internet]. European Heart Journal. 2012 ; 33 289.[citado 2024 nov. 16 ] Available from: http://eurheartj.oxfordjournals.org/content/33/suppl_1/19.full.pdf+html
Vancouver
Casella Filho A, Trombetta IC, Casella LB, Dourado PMM, Segre A, Favarato D, Borges LR, Negrão CE, Maranhão RC, Chagas ACP. Anti-inflammatory properties of HDL after short-term exercise training in patients with metabolic syndrome [Internet]. European Heart Journal. 2012 ; 33 289.[citado 2024 nov. 16 ] Available from: http://eurheartj.oxfordjournals.org/content/33/suppl_1/19.full.pdf+html
Artigo de periodico
Lipid Transfer to HDL is Higher in Marathon Runners than in Sedentary Subjects, but is Acutely Inhibited During the Run (2012)
Vaisberg, Mauro; Bachi, André Luis Lacerda; Latrilha, Conceicão; Dioguardi, Giuseppe S.; Bydlowski, Sergio P.; Maranhão, Raul Cavalcante
Fonte: Lipids. Unidades: FM, FCF
Assuntos: LIPÍDEOS (TRANSFERÊNCIA), CORRIDAS, MARATONISTAS, CITOCINAS, TREINAMENTO FÍSICO, LIPOPROTEÍNAS (METABOLISMO), SEDENTARISMO, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VAISBERG, Mauro et al. Lipid Transfer to HDL is Higher in Marathon Runners than in Sedentary Subjects, but is Acutely Inhibited During the Run. Lipids, v. 47, n. 7, p. 676-686, 2012Tradução . . Disponível em: https://doi.org/10.1007/s11745-012-3685-y. Acesso em: 16 nov. 2024.
APA
Vaisberg, M., Bachi, A. L. L., Latrilha, C., Dioguardi, G. S., Bydlowski, S. P., & Maranhão, R. C. (2012). Lipid Transfer to HDL is Higher in Marathon Runners than in Sedentary Subjects, but is Acutely Inhibited During the Run. Lipids, 47( 7), 676-686. doi:10.1007/s11745-012-3685-y
NLM
Vaisberg M, Bachi ALL, Latrilha C, Dioguardi GS, Bydlowski SP, Maranhão RC. Lipid Transfer to HDL is Higher in Marathon Runners than in Sedentary Subjects, but is Acutely Inhibited During the Run [Internet]. Lipids. 2012 ; 47( 7): 676-686.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s11745-012-3685-y
Vancouver
Vaisberg M, Bachi ALL, Latrilha C, Dioguardi GS, Bydlowski SP, Maranhão RC. Lipid Transfer to HDL is Higher in Marathon Runners than in Sedentary Subjects, but is Acutely Inhibited During the Run [Internet]. Lipids. 2012 ; 47( 7): 676-686.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s11745-012-3685-y
Artigo de periodico
Molecular mechanisms underlying statin effects on genes involved in the reverse cholesterol transport (2012)
Cerda, Alvaro; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Drug Metabolism and Drug Interactions. Unidade: FCF
Assuntos: LIPOPROTEÍNAS LDL, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro e HIRATA, Mario Hiroyuki e HIRATA, Rosario Dominguez Crespo. Molecular mechanisms underlying statin effects on genes involved in the reverse cholesterol transport. Drug Metabolism and Drug Interactions, v. 27, n. 2, p. 101-111, 2012Tradução . . Disponível em: https://doi.org/10.1515/dmdi-2012-0007. Acesso em: 16 nov. 2024.
APA
Cerda, A., Hirata, M. H., & Hirata, R. D. C. (2012). Molecular mechanisms underlying statin effects on genes involved in the reverse cholesterol transport. Drug Metabolism and Drug Interactions, 27( 2), 101-111. doi:10.1515/dmdi-2012-0007
NLM
Cerda A, Hirata MH, Hirata RDC. Molecular mechanisms underlying statin effects on genes involved in the reverse cholesterol transport [Internet]. Drug Metabolism and Drug Interactions. 2012 ; 27( 2): 101-111.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1515/dmdi-2012-0007
Vancouver
Cerda A, Hirata MH, Hirata RDC. Molecular mechanisms underlying statin effects on genes involved in the reverse cholesterol transport [Internet]. Drug Metabolism and Drug Interactions. 2012 ; 27( 2): 101-111.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1515/dmdi-2012-0007
Trabalho de evento-resumo periodico
Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in Caco-2 cells (2010)
Genvigir, Fabiana Dalla Vecchia; Rodrigues, Alice Cristina ; Hirata, Mario Hiroyuki ; Curi, Rui; Hirata, Rosario Dominguez Crespo
Fonte: Clinical Chemistry and Laboratory Medicine. Nome do evento: Santorini Conference Biologie Prospective. Unidades: FCF, ICB
Assuntos: EXPRESSÃO GÊNICA, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana Dalla Vecchia et al. Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in Caco-2 cells. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 16 nov. 2024. , 2010
APA
Genvigir, F. D. V., Rodrigues, A. C., Hirata, M. H., Curi, R., & Hirata, R. D. C. (2010). Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in Caco-2 cells. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Genvigir FDV, Rodrigues AC, Hirata MH, Curi R, Hirata RDC. Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in Caco-2 cells. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A66 res. B11.[citado 2024 nov. 16 ]
Vancouver
Genvigir FDV, Rodrigues AC, Hirata MH, Curi R, Hirata RDC. Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in Caco-2 cells. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A66 res. B11.[citado 2024 nov. 16 ]
Trabalho de evento-resumo periodico
Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression (2010)
Cerda, Alvaro; Genvigir, Fabiana Dalla Vecchia; Rodrigues, Alice Cristina ; Arazi, Simone Sorkin; Oliveira, Raquel; Dórea, Egidio Lima; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Clinical Chemistry and Laboratory Medicine. Nome do evento: Santorini Conference Biologie Prospective. Unidades: HU, FCF
Assuntos: POLIMORFISMO, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression. Clinical Chemistry and Laboratory Medicine. Berlin: Hospital Universitário, Universidade de São Paulo. . Acesso em: 16 nov. 2024. , 2010
APA
Cerda, A., Genvigir, F. D. V., Rodrigues, A. C., Arazi, S. S., Oliveira, R., Dórea, E. L., et al. (2010). Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression. Clinical Chemistry and Laboratory Medicine. Berlin: Hospital Universitário, Universidade de São Paulo.
NLM
Cerda A, Genvigir FDV, Rodrigues AC, Arazi SS, Oliveira R, Dórea EL, Hirata MH, Hirata RDC. Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A64-A64 res. B4.[citado 2024 nov. 16 ]
Vancouver
Cerda A, Genvigir FDV, Rodrigues AC, Arazi SS, Oliveira R, Dórea EL, Hirata MH, Hirata RDC. Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A64-A64 res. B4.[citado 2024 nov. 16 ]

Unidades USP

ReP

Filtros

Autores

Autores USP

Assuntos